Clinic
Geisinger Bloomsburg Hospital
Geisinger Bloomsburg Hospital was paid $7.17M by Medicaid between Jun 2018 and Dec 2024, across 191 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.
33Billing provider infoGEISINGER BLOOMSBURG HOSPITAL
BLOOMSBURG, PA 17815
BLOOMSBURG, PA 17815
33aNPI1821198755assigned 09/22/2006
33bProvider typeClinic/Center
28Total paid$7.17M
24GClaims212,678
24DCodes billed191
24AFirst – last monthJun 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#24 of 176
Median peer was paid$441K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27 | $6K | |
| 2019 | 97 | $5K | |
| 2020 | 14,047 | $437K | |
| 2021 | 64,635 | $2.24M | |
| 2022 | 45,858 | $1.69M | |
| 2023 | 49,566 | $1.54M | |
| 2024incomplete | 38,448 | $1.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 8,947 | 8,568 | $1.19M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 15% | 5,015 | 4,882 | $1.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 8,726 | 8,350 | $872K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.5% | 10,913 | 9,075 | $679K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.4% | 8,638 | 8,374 | $604K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5.3% | 6,163 | 5,134 | $382K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.9% | 3,372 | 3,277 | $278K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 842 | 813 | $150K |
| 80053 | Comprehensive metabolic panel | 2.0% | 13,982 | 13,303 | $141K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 1,709 | 1,664 | $136K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 4,085 | 3,901 | $107K |
| 87631 | 1.2% | 626 | 608 | $84K |
179 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 14,434 | $74K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 1.0% | 87 | $73K |
| 84702 | <1% | 4,028 | $62K | |
| 87481 | <1% | 782 | $54K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 2,637 | $48K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 480 | $45K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,337 | $45K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,080 | $42K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,865 | $39K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 147 | $37K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,180 | $37K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,103 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,057 | $35K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,378 | $33K |
| 76830 | Ultrasound, transvaginal | <1% | 530 | $31K |
| 82043 | <1% | 4,511 | $30K | |
| 84484 | <1% | 3,416 | $29K | |
| D0120 | Dental checkup, returning patient | <1% | 77 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 420 | $28K |
| 0100U | <1% | 82 | $27K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,163 | $27K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 708 | $27K |
| 82570 | <1% | 4,618 | $27K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 362 | $25K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,255 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,581 | $20K |
| 83605 | <1% | 2,892 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,124 | $18K |
| 80061 | Lipid panel | <1% | 1,462 | $18K |
| G0378 | Hospital observation service, per hour | <1% | 24 | $17K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 481 | $17K |
| 83690 | <1% | 3,482 | $15K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 47 | $15K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 307 | $14K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 462 | $14K |
| 83735 | <1% | 2,254 | $13K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 356 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,340 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,727 | $12K |
| 85027 | <1% | 1,679 | $11K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 96 | $11K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 122 | $10K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 341 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,378 | $9K |
| 81025 | <1% | 2,241 | $9K | |
| 93971 | <1% | 114 | $8K | |
| 83880 | <1% | 298 | $8K | |
| 87511 | <1% | 394 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,995 | $8K |
| 87430 | <1% | 1,233 | $8K | |
| 87150 | <1% | 118 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 205 | $7K |
| 76770 | <1% | 131 | $7K | |
| 86803 | <1% | 342 | $6K | |
| 300 | Patient transfer system <300 | <1% | 87 | $6K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 78 | $6K |
| 450 | Pov group 1 hd 301-450 lbs | <1% | 27 | $6K |
| 76536 | <1% | 102 | $6K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 1,034 | $6K |
| 81001 | <1% | 2,190 | $6K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 454 | $5K |
| 76642 | <1% | 100 | $5K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 45 | $5K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 42 | $5K |
| 73610 | <1% | 202 | $4K | |
| 73564 | <1% | 167 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,257 | $4K |
| 82607 | <1% | 335 | $4K | |
| 73630 | <1% | 285 | $4K | |
| 82805 | <1% | 115 | $4K | |
| 86850 | <1% | 450 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 94 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 128 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 92 | $3K |
| 84100 | <1% | 564 | $3K | |
| 77066 | Tomosynthesis, mammo | <1% | 31 | $3K |
| 71250 | <1% | 49 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $3K |
| 81003 | <1% | 867 | $2K | |
| 82728 | <1% | 207 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 24 | $2K |
| 86901 | <1% | 482 | $2K | |
| 86900 | <1% | 482 | $2K | |
| 87340 | <1% | 147 | $2K | |
| 84439 | <1% | 281 | $2K | |
| 82248 | <1% | 326 | $2K | |
| 85610 | <1% | 776 | $2K | |
| 82565 | <1% | 357 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 113 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $2K |
| 83540 | <1% | 230 | $2K | |
| 87186 | <1% | 237 | $2K | |
| 85379 | <1% | 192 | $2K | |
| 73130 | <1% | 125 | $2K | |
| D1120 | Dental cleaning, child | <1% | 48 | $2K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 37 | $2K |
| 83655 | <1% | 156 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 45 | $2K |
| 73030 | <1% | 75 | $1K | |
| 73110 | <1% | 103 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 113 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $1K |
| D0240 | <1% | 44 | $1K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 100 | $1K |
| D1206 | Topical application of fluoride varnish | <1% | 130 | $1K |
| D0272 | Bitewings - two radiographic images | <1% | 55 | $1K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 100 | $1K |
| 80050 | General health panel | <1% | 30 | $1K |
| 86762 | <1% | 67 | $1K | |
| 70486 | <1% | 13 | $1K | |
| 86140 | <1% | 461 | $1K | |
| 72100 | <1% | 47 | $1K | |
| 86618 | <1% | 48 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 80 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 90 | $1K |
| 74018 | <1% | 61 | $963.20 | |
| 83550 | <1% | 202 | $960.89 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 46 | $943.40 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,680 | $931.86 |
| 90715 | <1% | 106 | $927.44 | |
| 82950 | <1% | 143 | $918.86 | |
| 87077 | <1% | 119 | $808.49 | |
| 82962 | <1% | 592 | $716.81 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 12 | $685.69 |
| 80321 | <1% | 50 | $604.55 | |
| 82077 | <1% | 25 | $580.80 | |
| X0592 | <1% | 12 | $568.20 | |
| 82375 | <1% | 116 | $553.72 | |
| 80076 | <1% | 73 | $551.34 | |
| 85652 | <1% | 189 | $542.67 | |
| 80179 | <1% | 14 | $471.24 | |
| 86780 | <1% | 27 | $410.26 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,989 | $405.49 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 12 | $357.03 |
| 87088 | <1% | 47 | $345.99 | |
| 83050 | <1% | 115 | $290.39 | |
| 84146 | <1% | 12 | $286.32 | |
| 94644 | <1% | 12 | $269.34 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 467 | $267.73 |
| 86592 | <1% | 62 | $252.56 | |
| 85046 | <1% | 30 | $191.32 | |
| 82746 | <1% | 17 | $178.11 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,405 | $176.39 |
| 73140 | <1% | 13 | $158.83 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,925 | $131.76 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,707 | $121.86 |
| 83525 | <1% | 12 | $105.93 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $93.90 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 636 | $70.61 |
| 85007 | <1% | 15 | $68.44 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 347 | $67.84 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,066 | $58.85 |
| 85730 | <1% | 17 | $47.36 | |
| 85018 | <1% | 12 | $37.77 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 463 | $29.59 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $26.76 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 230 | $23.02 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,513 | $8.88 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 39 | $6.98 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 69 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 110 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 0% | 120 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 71 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 132 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 27 | $0.00 |
| J8501 | Aprepitant, oral, 5 mg | 0% | 153 | $0.00 |
| D7140 | Extraction, erupted tooth or exposed root | 0% | 32 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 42 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 17 | $0.00 |
| D1351 | Sealant - per tooth | 0% | 13 | $0.00 |
| J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | 0% | 18 | $0.00 |
| 90686 | 0% | 13 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 275 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 57 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 27 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 35 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 110 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 28 | $0.00 |
| A6211 | Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (SYSTEM DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Jersey Shore Hospital | Jersey Shore, PA | $2.17M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.